It can be difficult to set up a clinical research site for the first time. What are some of the most common issues? In today’s episode, Darshan Kulkarni joins clinical research expert Kelly Willenberg to talk about setting up a compliant clinical...
Many ethical concerns are raised after patients die in clinical trials. Once a patient dies, what happens to their consent? Join Darshan Kulkarni as he talks with professor of philosophy Peter Koch about the rights patients have after death. Plus...
Setting up a clinical trial site can be a difficult process. How can you create a successful trial site? Join Darshan Kulkarni as he talks with clinical research site adviser Deena Bernstein about how to set up a site while remaining compliant.
Are pharmaceutical companies allowed to provide financial assistance for travel, lodging and other expenses to certain patients? Join FDA regulatory attorney Darshan Kulkarni as he discusses why the Office of Inspector General (OIG) decided in favor...
Transparency, or the practice of disclosing clinical trial data, is highly important in clinical research. What happens when companies decide to not publish all of their clinical trial results, and fall out of compliance with the FDAA? FDA...
What are the four branches of patient centricity, and how can they apply to your company? In this episode, Darshan Kulkarni explains how companies can foster patient centricity through privacy, transparency, innovation and access. Plus, how the FDA...